FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...